XTRA:1SXPLife Sciences
SCHOTT Pharma (XTRA:1SXP) Stock Trails Its Margin Resilience And Valuation Gap
SCHOTT Pharma KGaA stock has cooled after a sharp 90 day climb of about 33%, closing today at €21.80, yet the fresh Q3 numbers tell a more resilient story. Revenue reached €281.76m and basic earnings per share came in at €0.26, supported by an earnings before interest, tax, depreciation and amortisation margin of 26.8% that still sits in the high twenties.
That mix of strong profitability and a trailing P/E of 24.1x, below both life sciences peers and the sector average, sets up a picture...